免费资料大全-免费完整资料

67 press releases in total

2021

Feb 26, 2021

Jacobio has been Selected as Constituent Stock of Hang Seng Composite Index

[More]

2020

Dec 1, 2020

Jacobio Announces First Patient Enrolled in Phase I Clinical Trial of BET Inhibitor JAB-8263

[More]
Jun 1, 2020

AbbVie pens cancer pact with U.S.-China biotech Jacobio

2019

Oct 10, 2019

Jacobio Receives IND Approval for SHP2 Inhibitor JAB-3312 from China CDE

[More]
Sep 16, 2019

Jacobio Enrolled First Patient in a Clinical Study of JAB-3312 in U.S.

[More]
Jul 9, 2019

Jacobio Receives IND Approval for SHP2 Inhibitor JAB-3312 from U.S. FDA

[More]
Jun 19, 2019

Jacobio's Innovative Drug Awarded Orphan Drug Designation for the Treatment of Esophageal Cancer by US FDA

[More]

Pages